Way more than an everyday interest in IP
The most significant advances in medical treatments are being made with biological products. As biological medicines are significantly more expensive than traditional small molecule drugs, upward pressure is being placed on health spending. For example, in the United States, biological medicines accounted for 40% of all prescription drugs spending and 70% of the increase in read more…
Australia’s digital health sector received a major boost in April this year when the Federal Government announced a $55 million cash injection to launch the new Digital Health Cooperative Research Centre (CRC) and its programs which will bring together a consortium of more than 60 health, medical technology and pharmaceutical companies, universities and research institutes read more…
The Trump Organisation owns a lot of domain names – around 3,000, for everything from <TrumpOnTheRocks.com> to <TrumpRussia.com>. Unfortunately for the President, this impressive portfolio doesn’t include <TrumpHotels.org>. Golf enthusiasts, honeymooners and high-powered executives wanting to stay at one of Trump’s 11 hotels will not find what they are looking for at <TrumpHotels.org>. The website read more…
The United States Government, acting through the United States Postal Service (USPS) has been ordered to pay US $3.5 million for copyright infringement after accidentally using a replica Statue of Liberty on its 2011 Forever Stamp. The creator of the replica sculpture, Robert S. Davidson, brought a claim against the United States for infringing his read more…
We can all be guilty of promising more than we can deliver – but for a patentee, that can be fatal for the validity of your patent. Under Australian patent law, inventions must be ‘useful’ in order to be patentable, and one of the complex elements of this requirement is whether any promises made with read more…
As we wrap up our week of insights on the biotech industry and coverage of #Bio2018, what is clear is that for many biotech innovations, the story is just beginning. From landmark developments in genetic engineering techniques, the integration of AI and digital technologies into health care products and services and the increasing investment in read more…
Continuing our series on biotechnology for #Bio2018, this post looks at the development of new gene editing and genetic engineering techniques – a key trend shaping the biotechnology industry. New genome editing techniques, such as CRISPR/Cas9, have made editing genomic material cheap, efficient and accessible. These new techniques have opened up a plethora of opportunities read more…
Couldn’t make it to #Bio2018? This week, Anna Feros reports on her insights from the BIO International Convention in Boston, hosted by the Biotechnology Innovation Organization (BIO), which represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers and related organizations. The first full day at BIO2018 kicked off with an inspirational keynote session led by read more…
As keepers of the world’s ‘big data’, many of the major tech companies are naturally well placed to turn to the data-hungry development of artificial intelligence, or AI. And while AI is a hot topic in almost every industry, its presence and potential application in healthcare is exploding. AI – what is it exactly? In read more…